太倉(cāng)市沿江臨滬，地處沿海經(jīng)濟(jì)帶和長(zhǎng)三角經(jīng)濟(jì)圈核心位置，距離上海張江藥谷和蘇州BioBAY均只需1小時(shí)車程，高鐵900秒抵達(dá)上海虹橋站，2027年地鐵接軌上海。太倉(cāng)港是長(zhǎng)江外貿(mào)第一大港，位列全球集裝箱港口第22位。太倉(cāng)將生物醫(yī)藥作為重點(diǎn)發(fā)展的戰(zhàn)略性新興產(chǎn)業(yè)，圍繞新藥研發(fā)生產(chǎn)、醫(yī)療器械、醫(yī)藥服務(wù)外包等領(lǐng)域，已集聚了昭衍新藥、康乃德生物、中美冠科、含光微納、思納福、賽業(yè)模式生物、依科賽生物等400余家生物醫(yī)藥企業(yè)，形成了完善的上下游產(chǎn)業(yè)鏈。
Taicang is not only borders Shanghai but also faces the Yangtze River, located in the core position of the coastal economic belt and the Yangtze River Delta economic circle. It is only about an one-hour drive both from Shanghai Zhangjiang Pharmaceutical Valley and Suzhou BioBAY and 900 seconds from Taicang railway station to Shanghai Hongqiao railway station. In additon, the subway will be connected to Shanghai in 2027. Taicang port is the largest foreign trade port on the Yangtze River and the 22th in the global container ports. Taicang prioritized Biomedical as a strategic industry, with a focus on new medical development and production, medical devices, and pharmaceutical outsourcing services. The biomedical industry has gathered nearly 400 biomedical enterprises in the city, including Joinn Laboratories, Connect Biopharmaceuticals, Crown Bioscience, HiComp Microtech, Sinafu Medical Technology, Cyagen Biosciences, ExCell Biotech and other potential biomedical enterprises, Already formed a complete industrial chain.